Cargando…

Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis

Pulmonary lymphangitic carcinomatosis (PLC) is associated with a poor prognosis in patients with non-small cell lung cancer (NSCLC). We sought to determine prognostic value of pretherapeutic fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in NSCLC wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yong-Jin, Im, Yunjoo, Kwon, O. Jung, Han, Joungho, Ahn, Myung-Ju, Kim, Jhingook, Um, Sang-Won, Choi, Joon Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825376/ https://www.ncbi.nlm.nih.gov/pubmed/36611038 http://dx.doi.org/10.1038/s41598-022-24875-2

Ejemplares similares

Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer
por: Im, Yunjoo, et al.
Publicado: (2021)

Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma
por: Lim, Jun Hyeok, et al.
Publicado: (2020)

Lymphangitic Carcinomatosis of Possible Urothelial Origin
por: Saini, Tanjot, et al.
Publicado: (2023)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

Acute kidney injury associated with lymphangitic carcinomatosis
por: Sannier, Aurélie, et al.
Publicado: (2018)

Pulmonary lymphangitic carcinomatosis secondary to ureteral cancer
por: Sugimoto, Hiroshi, et al.
Publicado: (2021)

Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using (18)F-FDG PET/CT: A case report
por: Wang, Yueqi, et al.
Publicado: (2019)

Pulmonary Lymphangitic Carcinomatosis due to Renal Cell Carcinoma
por: Guddati, Achuta K., et al.
Publicado: (2012)

Relapsed breast adenorcarcinoma presenting as pulmonary lymphangitic carcinomatosis
por: Loh, KP, et al.
Publicado: (2012)

Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
por: Park, Yong-Jin, et al.
Publicado: (2021)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Pulmonary lymphangitic carcinomatosis from squamous cell carcinoma of the cervix
por: Kanthan, Rani, et al.
Publicado: (2010)

Lymphangitic Carcinomatosis as a Cause of Malignant Transient Pleural Transudate
por: Garcia Sevila, Raquel, et al.
Publicado: (2009)

Delays in Diagnosis of Pulmonary Lymphangitic Carcinomatosis due to Benign Presentation
por: Pandey, Swati, et al.
Publicado: (2020)

Pulmonary lymphangitic carcinomatosis with ground‐glass opacities as presentation of prostate cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Cutaneous lymphangitic carcinomatosis: A rare metastasis from cervical cancer
por: Burbano, Javier, et al.
Publicado: (2018)

A rare presentation of Pulmonary Lymphangitic Carcinomatosis in cancer of lip: case report
por: Babu, Sajith, et al.
Publicado: (2011)

Rhabdoid collecting duct carcinoma with lymphangitic carcinomatosis causing acute lethal chylopericardium
por: Alvarez Moreno, Juan Carlos, et al.
Publicado: (2020)

Pulmonary lymphangitic carcinomatosis from gallbladder cancer mimicking diffuse alveolar haemorrhage
por: Higo, Hisao, et al.
Publicado: (2020)

Everolimus/prednisone/tacrolimus: Primary lung adenocarcinoma and lymphangitic carcinomatosis: case report
Publicado: (2018)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

The value of virtual bronchoscopic navigation and radial endobronchial ultrasound-guided transbronchial lung cryobiopsies for pulmonary lymphangitic carcinomatosis
por: Pang, Lingling, et al.
Publicado: (2020)

Whole-body MRI versus (18)F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
por: Wang, Danyang, et al.
Publicado: (2018)

Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature review
por: Zhuang, Li, et al.
Publicado: (2014)

Lymphangitic Retroperitoneal Carcinomatosis Occurring From Metastatic Sarcomatoid Chromophobe Renal Cell Carcinoma
por: Alimchandani, Meghna, et al.
Publicado: (2014)

Occult pulmonary lymphangitic carcinomatosis presenting as 'chronic cough' with a normal HRCT chest
por: Jinnur, Praveen K., et al.
Publicado: (2016)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

A Case of Rapidly Deteriorating Lymphangitic Carcinomatosis in a Patient with Stage IV Pancreatic Cancer
por: Aslam, Hafiz M, et al.
Publicado: (2019)

The Value of (18)F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
por: Luo, Jurui, et al.
Publicado: (2016)

Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin’s lymphoma
por: Rogasch, Julian M. M., et al.
Publicado: (2018)

A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
por: Natsume, Maika, et al.
Publicado: (2017)

Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer
por: Fumet, Jean-David, et al.
Publicado: (2018)

Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report
por: Corredor-Orlandelli, David, et al.
Publicado: (2023)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET
por: Le Boulc’h, Morwenn, et al.
Publicado: (2021)

Pulmonary Lymphangitic Carcinomatosis: An Atypical Presentation Leading to Discovery of Multi-Organ Metastasis With Unknown Occult Primary Malignancy
por: Al-Bayati, Mustafa, et al.
Publicado: (2022)

Quantitative assessment of the asphericity of pretherapeutic FDG uptake as an independent predictor of outcome in NSCLC
por: Apostolova, Ivayla, et al.
Publicado: (2014)

Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy
por: Lucia, François, et al.
Publicado: (2020)

Cerebellum/liver index in pretherapeutic (18)F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance
por: Godard, François, et al.
Publicado: (2022)

Excellent Response with Ado-Trastuzumab Emtansine in a Patient with Relapsed Metastatic Breast Cancer Presenting with Pulmonary Lymphangitic Carcinomatosis
por: Yu, Zhou, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eo2ik2d6rluaemtgdnglhngh9f